@AmerAcadPeds, many changes since your 2021 statement opposing off-label vax:☑️Favorable safety & eff. data for 5-11; 0-2 trial success☑️Indirect protection from vaccinated reduced w/Omi☑️<5 EUA delayed☑️Rising <5 hospitalizations & more. Will you provide an update? #offlabelu5
Another view (same source) shows how wildly out of proportion the <5 hospitalization rates are compared to previous waves. Now approaching levels in 18-49.
Notably, 0-4 is the only age group that remains 100% unvaccinated while also being highly exposed via childcare with limited (or no) ability to mask. Indirect protection from vaxxed household members also down with Omi. A perfect storm behind the data!
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Today, on #KidsVaccinesDay, I want to talk about an off-label *option* to vaccinate children < 5. Is that getting ahead of the science, you ask? No! The science and the ethics align in support of #offlabelU5. Read on… 🧵1/n
First, let’s talk about how we got here. What happened with Pfizer’s pediatric trial? @dr_kkjetelina did an excellent explainer on this topic. Bottom line: 3 mcg worked in kids 6m – 2 years, but the dose was too low for 2-5s. yourlocalepidemiologist.substack.com/p/why-did-the-…
Very important note: No safety signals were observed in either age group.